相关标志物对COVID-19并发急性肾损伤及预后的预测价值

doi:10.3969/j.issn.1006-6233.2024.02.033

摘要
图/表
参考文献
相关文章 (15)

[1] Chan L,Chaudhary K,Saha A,et al.AKI in hospitalized patients with COVID-19[J].Journal of the American Society of Nephrology,2021,32(1):151-160.
[2] Vogel M J,Mustroph J,Staudner S T,et al.Kidney injury molecule-1:potential biomarker of acute kidney injury and disease severity in patients with COVID-19[J].Journal of Nephrology,2021,34(4):1007-1018.
[3] Yasar E,Ozger H S,Yeter H H,et al.Could urinary kidney injury molecule-1 be a good marker in subclinical acute kidney injury in mild to moderate COVID-19 infection?[J].International Urology and Nephrology,2022,54(3):627-636.
[4] Racovitan D,Hogeweg M,Doevelaar A A,et al.Urinary biomarkers to predict acute kidney damage and mortality in COVID-19[J].Clinical Nephrology,2023,99(4):161-171.
[5] Casas-Aparicio G,Alvarado-de la Barrera C,Escamilla-Illescas D,et al.Role of urinary kidney stress biomarkers for early recognition of subclinical acute kidney injury in critically Ill COVID-19 patients[J].Biomolecules,2022,12(2):275.
[6] Xu K,Shang N,Levitman A,et al.Elevated neutrophil gelatinase-associated lipocalin is associated with the severity of kidney injury and poor prognosis of patients with COVID-19[J].Kidney International Reports,2021,6(12):2979-2992.
[7] Azam T U,Shadid H R,Blakely P,et al.Soluble urokinase receptor (SuPAR) in COVID-19-related AKI[J].Journal of the American Society of Nephrology,2020,31(11):2725-2735.
[8] Matuszewski M,Ladny J,Rafique Z,et al.Prediction value of soluble urokinase plasminogen activator receptor (suPAR) in COVID-19 patients - a systematic review and meta-analysis[J].Annals of Agricultural and Environmental Medicine,2023,30(1):142-147.
[9] Hayek S S,Leaf D E,Samman Tahhan A,et al.Soluble urokinase receptor and acute kidney Injury[J].New England Journal of Medicine,2020,382(5):416-426.
[10] Wu W,Wang W,Liang L,et al.Treatment with quercetin inhibits SARS-CoV-2 N protein-induced acute kidney injury by blocking Smad3-dependent G1 cell-cycle arrest[J].Molecular Therapy,2023,31(2):344-361.
[11] Norvik J V,Harskamp L R,Nair V,et al.Urinary excretion of epidermal growth factor and rapid loss of kidney function[J].Nephrology Dialysis Transplantation,2021,36(10):1882-1892.
[12] Casas-Aparicio G,Alvarado-de la Barrera C,Escamilla-Illescas D,et al.Longitudinal analysis of urinary cytokines and biomarkers in COVID-19 patients with subclinical acute kidney injury[J].International Journal of Molecular Sciences,2022,23(23):15419.
[13] Menez S,Moledina D G,Thiessen-Philbrook H,et al.Prognostic significance of urinary biomarkers in patients hospitalized with COVID-19[J].American Journal of Kidney Diseases,2022,79(2):257-267.e1.
[14] Yildirim C,Ozger H S,Yasar E,et al.Early predictors of acute kidney injury in COVID-19 patients[J].Nephrology,2021,26(6):513-521.
[15] Kim S-Y,Hong D-Y,Kim J-W,et al.Predictive values of procalcitonin and presepsin for acute kidney injury and 30-day hospital mortality in patients with COVID-19[J].Medicina,2022,58(6):727.
[16] Shen Y,Cheng C,Zheng X,et al.Elevated procalcitonin is positively associated with the severity of COVID-19:a meta-analysis based on 10 cohort studies[J].Medicina,2021,57(6):594.
[17] Chen Z,Gao C,Yu H,et al.Hypophosphatemia is an independent risk factor for AKI among hospitalized patients with COVID-19 infection[J].Renal Failure,2021,43(1):1329-1337.
[18] Wang R,He M,Kang Y.Hypophosphatemia at admission is associated with increased mortality in COVID-19 patients[J].International Journal of General Medicine,2021,(14):5313-5322.
[19] Schnabel K,Garam N,Ledó N,et al.Urinary albumin-to-creatinine ratio and serum albumin are predictors of acute kidney injury in non-ventilated COVID-19 patients:a single-center prospective cohort study[J].International Urology and Nephrology,2022,55(3):711-720.
[20] Renberg M,Jonmarker O,Kilhamn N,et al.Renal resistive index is associated with acute kidney injury in COVID-19 patients treated in the intensive care unit[J].The Ultrasound Journal,2021,13(1):3.
[21] Cruz E G,Broca Garcia B E,Sandoval D M,et al.Renal resistive index as a predictor of acute kidney injury and mortality in COVID-19 critically Ill patients[J].Blood Purification,2022,51(4):309-316.
[22] Huang Q,Li J,Lyu S,et al.COVID-19 associated kidney impairment in adult:qualitative and quantitative analyses with non-enhanced CT on admission[J].European Journal of Radiology,2020,(131):109240.
[23] Russo E,Tagliafico A S,Derchi L,et al.Role of renal parenchyma attenuation and perirenal fat stranding in chest CT of hospitalized patients with COVID-19[J].Journal of Clinical Medicine,2023,12(3):929.
[24] Paranjpe I,Chaudhary K,Johnson K W,et al.Association of SARS-CoV-2 viral load at admission with in-hospital acute kidney injury:a retrospective cohort study[J].A.L.Conroy.PLOS ONE,2021,16(2):247366.
[25] Caceres P S,Savickas G,Murray S L,et al.High SARS-CoV-2 viral load in urine sediment correlates with acute kidney injury and poor COVID-19 outcome[J].Journal of the American Society of Nephrology,2021,32(10):2517-2528.
[26] Kim I S,Kim D H,Lee H W,et al.Role of increased neutrophil extracellular trap formation on acute kidney injury in COVID-19 patients[J].Frontiers in Immunology,2023,(14):1122510.